Rimegepant has been recommended for adults who cannot take other medicines or do not respond to them. A migraine charity said it brought "new hope", especially for those who suffer debilitating ...

Recently, a new class of migraine drugs known as gepants has entered the market. This includes rimegepant, sold by Pfizer under the brand name Vydura, and ubrogepant, marketed as Ubrelvy by Abbvie.

Rimegepant, taken every other day, will be available only to adults who have tried at least three other preventative drugs and still have migraines on between four and 15 days every month.

But in recent years, a new generation of migraine drugs called gepants has emerged. This includes rimegepant, which is sold by US pharma giant Pfizer under the brand name Vydura, and ubrogepant ...

Three newer migraine drugs were included in the analysis: lasmiditan (Reyvow), rimegepant (Nurtec), and ubrogepant (Ubrelvy). Lasmiditan is a serotonin (5-HT) 1F receptor agonist. Rimegepant and ...

Migraine drugs can represent big money for pharmaceutical firms, as shown when Pfizer acquired Biohaven -- which developed rimegepant -- for more than $10 billion in 2022. These new drugs have ...

Newer drugs, such as lasmiditan, rimegepant and ubrogepant were also included in the study, but were not as effective as triptans. Lead author Andrea Cipriani, a professor of psychiatry at the ...